The FDA has approved an updated treatment protocol for a drug called Sublocade. WebMD Health News

A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another lawsuit against...

A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutid...

Surgifort® Human Milk Fortifier, Developed by Prolacta Bioscience, Is the First Human Milk-Based Nutritional Fortifier Indicated for Term In...

The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized neuromodulatio...

Associated Press (AP) — Barely a week after mass firings at the Food and Drug Administration, some probationary staffers received unexpected...

Feel Good Foods Inc. issued a voluntary recall for thousands of cases of its Mac & Cheese Bites in February due to the possible presence of...

An Arizona company recalled the product in January over the possibility of it containing an undeclared allergen.

The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component SALT LAKE CITY, Feb....

The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the end to the boomi...

By Deidre McPhillips, CNN(CNN) — Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and...

Shares of Hims & Hers tumble 21% after FDA says semaglutide is no longer in shortage

By The Associated PressShortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of t...

The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S. Food and Drug Admi...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.